Back
Panbela Therapeutics Vs. Palisade Bio Industry Stock Comparison
Sell
16
PBLA
Panbela Therapeutics
Last Price:
0.43
Seasonality Move:
-4.94%
Sell
35
PALI
Palisade Bio
Last Price:
5.36
Seasonality Move:
-22.19%
Sell
16
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.40. The Score for PBLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $5.85. The Score for PALI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PALI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $5.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing slight selling pressure.
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.99 | Sell |
| Chaikin Money Flow: | -48335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.39 - 0.47) | Sell |
| Bollinger Bands (100): | (-1.98 - 7.92) | Sell |
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 44.62 | Sell |
| Chaikin Money Flow: | -28692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.58 - 7.28) | Sell |
| Bollinger Bands (100): | (5.31 - 8.13) | Sell |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 0.52 | Sell |
| 200-day SMA: | 11.87 | Sell |
| 8-day EMA: | 0.42 | Sell |
| 20-day EMA: | 0.44 | Sell |
| 50-day EMA: | 1.07 | Sell |
| 200-day EMA: | 647.44 | Sell |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.4 | Sell |
| 20-day SMA: | 6.67 | Sell |
| 50-day SMA: | 5.96 | Sell |
| 200-day SMA: | 8.24 | Sell |
| 8-day EMA: | 6.4 | Sell |
| 20-day EMA: | 6.44 | Sell |
| 50-day EMA: | 6.35 | Sell |
| 200-day EMA: | 22.11 | Sell |
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,220.22 per share, and an increase next year of $3.68 per share.
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.73 per share, and an increase next year of $3.45 per share.
Panbela Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Palisade Bio Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||